These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9368162)

  • 1. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group.
    J Cataract Refract Surg; 1997 Oct; 23(8):1183-9. PubMed ID: 9368162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery.
    Rossetti L; Bujtar E; Castoldi D; Torrazza C; Orzalesi N
    J Cataract Refract Surg; 1996; 22 Suppl 1():794-9. PubMed ID: 9279674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.
    Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J
    Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial.
    Miyake K; Masuda K; Shirato S; Oshika T; Eguchi K; Hoshi H; Majima Y; Kimura W; Hayashi F
    Jpn J Ophthalmol; 2000; 44(1):58-67. PubMed ID: 10698027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema].
    Miyake K; Masuda K; Shirato S; Oshika T; Eguchi K; Hoshi H; Majima Y; Kimura W; Hayashi F
    Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):522-30. PubMed ID: 9754024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.
    Miyake K; Ota I; Maekubo K; Ichihashi S; Miyake S
    Arch Ophthalmol; 1999 Jan; 117(1):34-40. PubMed ID: 9930158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of cystoid macular edema with diclofenac eyedrops in intracapsular cataract extraction using the Choyce Mark IX anterior chamber lens].
    Quentin CD; Behrens-Baumann W; Gaus W
    Fortschr Ophthalmol; 1989; 86(6):546-9. PubMed ID: 2696710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation.
    Kraff MC; Martin RG; Neumann AC; Weinstein AJ
    J Cataract Refract Surg; 1994 Mar; 20(2):138-44. PubMed ID: 8201562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K; Ota I; Miyake G; Numaga J
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
    Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
    Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation.
    Diestelhorst M; Schmidl B; Konen W; Mester U; Raj PS
    J Cataract Refract Surg; 1996; 22 Suppl 1():788-93. PubMed ID: 9279673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
    Miyake K; Nishimura K; Harino S; Ota I; Asano S; Kondo N; Miyake S
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5647-52. PubMed ID: 18055815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia.
    Miyake K; Ota I; Ibaraki N; Akura J; Ichihashi S; Shibuya Y; Maekubo K; Miyake S
    Arch Ophthalmol; 2001 Mar; 119(3):387-94. PubMed ID: 11231772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial.
    Barraquer RI; Alvarez de Toledo JP; Montané D; Escoto RM; Garcia Torres C; Bennani-Tazzi M
    Eur J Ophthalmol; 1998; 8(3):173-8. PubMed ID: 9793772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
    Rho DS
    J Cataract Refract Surg; 2003 Dec; 29(12):2378-84. PubMed ID: 14709300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
    Cardascia N; Palmisano C; Centoducati T; Alessio G
    Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery.
    Baiza-Duran LM; Quintana-Hau J; Tornero-Montaño R; Ortiz MI; Castañeda-Hernández G; Alanis-Villarreal L; Avalos-Urzua G; Bustos-Zermeño R; Domene-Hinojosa JL; Gómez-Bastar P; Ibañez-Hernandez MA; Morales-Gómez ME; Velasco-Gallegos G; Villar-Kuri J
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.